The significance of carotid artery atheromas on panoramic radiographs in the diagnosis of occult metabolic syndrome (Q46855865)

25 December 2017

title

The significance of carotid artery atheromas on panoramic radiographs in the diagnosis of occult metabolic syndrome (English)

1 reference

25 December 2017

1 reference

Arthur H Friedlander

1

1 reference

25 December 2017

Michael S Golub

series ordinal

2

1 reference

25 December 2017

publication date

1 January 2006

1 reference

25 December 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

25 December 2017

volume

101

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

95-101

1 reference

25 December 2017

The spread of the obesity epidemic in the United States, 1991-1998

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Metabolic syndrome and vascular disease: is nature or nurture leading the new epidemic of cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome, diabetes, and subclinicalatherosclerosis assessed by coronary calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Management of metabolic syndrome: aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The prevalence of calcified carotid artery atheromas on the panoramic radiographs of patients with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Cardiovascular morbidity and mortality associated with the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

A major health hazard: the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Diagnosis, prevention, and intervention for the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Cholesterol absorption and the metabolic syndrome: a new look at an old area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Impact of weight loss on the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

The new blood pressure guidelines: a digest.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.04.027

10.1016/J.TRIPLEO.2005.04.027

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

release_c4zdxwjxwjcqldd2nrq5wzmble

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c4zdxwjxwjcqldd2nrq5wzmble

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16360613

1 reference

25 December 2017